Abstract: The present application relates to an orally administered pharmaceutical composition or kit for eradicating Helicobacter pylori, including a complex of a non-absorbable antibiotic and a clay mineral. The pharmaceutical composition and kit of the present invention may further include a ?-lactam antibiotic and/or a gastric acid inhibitor.

Abstract: A pharmaceutical composition for treating Clostridioides difficile Infection (CDI), and a method for producing same. The pharmaceutical composition includes a complex of clay minerals, such as bentonite, and antibiotics, such as vancomycin. Accordingly, the pharmaceutical composition has an excellent treatment effect on CDI even with a significantly smaller amount of each of the existing antibiotics and clay minerals than the maximum recommended daily intake thereof, and has the effect of reducing side effects that can be caused by the massive intake of the antibiotics and clay minerals.

Abstract: According to one embodiment of the present invention, provided is a drug-clay mineral complex, in which the complex comprises a phospholipid, and the drug has an amine group.

Abstract: A drug and layered silicate composite is provided. The drug and layered silicate contains layered silicate powders and a drug compound bound to between layers of the silicate powders, wherein the drug compound is present in an amorphous state in the composite. Using such a composite may significantly improve absorption and bioavailability of a sorafenib compound.

Abstract: Disclosed are a controlled-release composition for oral administration comprising a complex of a hydrophilic alpha adrenergic blocker compound or its salt; and a clay mineral, and a method for preparing the same. The composition of the present disclosure has an in vivo release rate controlled further than that of conventional alpha adrenergic blocker compounds, thereby preventing side effects caused by a rapid increase in plasma drug concentration.

Abstract: Provided is a cosmetic composition comprising bentonite as an active ingredient. The cosmetic composition according to the present disclosure reduces the expression of inflammatory mechanism proteins and inflammatory mechanism genes in keratinocytes and hypodermal cells, exhibits an anti-inflammatory function, increases the moisture content of the skin, reduces redness in the skin, and increases the brightness of the skin, thereby being effective in skin whitening and skin moisturizing.

Abstract: Disclosed is an orally-administered pharmaceutical composition or kit for eradicating Helicobacter pylori comprising a complex of a non-absorbable antibiotic and a clay mineral. The pharmaceutical composition or kit of the present disclosure may further comprise a ?-lactam antibiotic and/or a gastric acid-suppressive agent.

Abstract: Provided is a pharmaceutical composition for preventing or treating metabolic bone diseases, containing bentonite as an active ingredient. The present disclosure relates to a composition for inhibiting bone resorption of osteoclasts and simultaneously, promoting bone formation of osteoblasts to be usable in the prevention or treatment of metabolic bone diseases such as osteoporosis, osteomalacia, osteopenia and bone atrophy.

Abstract: The present invention relates to a pharmaceutical composition for prevention, alleviation, and treatment of inflammatory bowel disease, the composition comprising a complex of a compound of Chemical Formula 1 or a pharmaceutically acceptable salt thereof and a clay mineral; a method for prevention, alleviation, and treatment of inflammatory bowel disease by using same; and a preparation method of the pharmaceutical composition.

Abstract: The present invention relates to a composition for oral administration with controlled release properties, comprising a complex of a compound of Chemical Formula 1 or a pharmaceutically acceptable salt thereof; and a clay mineral, and a method for preparing same.

Abstract: A composition for dyeing a bentonite, which includes a plant-derived polyphenol, and a method for dyeing a bentonite using the composition are provided. A composition for dyeing a bentonite, which includes a polyphenol such as lignin, pectin, tannin, and catechin, as a plant-derived material, and a method for dyeing a bentonite using the composition are provided.

Abstract: The present application relates to an orally administered pharmaceutical composition or kit for eradicating Helicobacter pylori, including a complex of a non-absorbable antibiotic and a clay mineral. The pharmaceutical composition and kit of the present invention may further include a ?-lactam antibiotic and/or a gastric acid inhibitor.

Abstract: A method for synthesizing high purity montmorillonite is disclosed. According to this synthesis method, bentonite is dissolved in aqua regia to produce a solution and then sodium hydroxide (NaOH) is added to the solution to produce a mixed solution. Then, the mixed solution is kept in a sealed state at a temperature of 90° C. inclusive to 100° C. exclusive to synthesize montmorillonite crystals.

Abstract: A drug and layered silicate composite is provided. The drug and layered silicate contains layered silicate powders; and a drug compound bound to between layers of the silicate powders, wherein the drug compound is present in an amorphous state in the composite. Using such a composite may significantly improve absorption and bioavailability of a sorafenib compound.

Abstract: A method for synthesizing high purity montmorillonite is disclosed. According to this synthesis method, bentonite is dissolved in aqua regia to produce a solution and then sodium hydroxide (NaOH) is added to the solution to produce a mixed solution. Then, the mixed solution is kept in a sealed state at a temperature of 90° C. inclusive to 100° C. exclusive to synthesize montmorillonite crystals.

Abstract: Provided are a method for crushing hard tungsten carbide (WC) scraps which is a pre-step of alkaline leaching and acid leaching processes for recycling of tungsten and cobalt, the method including mixing hard tungsten carbide (WC) scraps such as chips, wires, bolts, drills, etc., that are metalworking tools to be discarded after being used, with aluminum, followed by heating to a high temperature, to form an intermetallic compound, metal oxides, or mixtures thereof in a sponge form, and crushing the intermetallic compound, the metal oxides, or the mixtures thereof in a sponge form. Further, provided is a method for recovering tungsten and cobalt from hard tungsten carbide (WC) scrap powder through alkaline leaching and acid leaching methods.

Abstract: Provided are a method for crushing hard tungsten carbide (WC) scraps which is a pre-step of alkaline leaching and acid leaching processes for recycling of tungsten and cobalt, the method including mixing hard tungsten carbide (WC) scraps such as chips, wires, bolts, drills, etc., that are metalworking tools to be discarded after being used, with aluminum, followed by heating to a high temperature, to form an intermetallic compound, metal oxides, or mixtures thereof in a sponge form, and crushing the intermetallic compound, the metal oxides, or the mixtures thereof in a sponge form.

Abstract: Disclosed is a method of producing carbide and carbon nitride powders containing a binder, and cermet obtained from the same. The method includes preparing Ti—Ni alloy powders for Ti alloy powders and graphite, planetary-pulverizing the Ti—Ni alloy powders and the graphite, mortar-pulverizing the alloy powders and the graphite which are subject to the planetary-pulverizing, and performing heat treatment for the Ti—Ni alloy powders and the graphite that are pulverized. Cermet, which is made of the composite powders of carbide and carbon nitride/metal including both TiC which is ceramic material and Ni which is metal is provided.

Abstract: Provided is a portable ultraviolet device for exploring a mineral resource. The portable ultraviolet device for exploring the mineral resource may include a body, a visible component, an ultraviolet lamp assembly, and a darkroom component. The visible component is coupled to the body to pass through the body so that a mineral resource disposed at a lower portion of the body is observed from an upper side of the body. The ultraviolet lamp assembly part is coupled to the body to emit ultraviolet rays onto the mineral resource. The darkroom component is coupled to a bottom surface of the body to surround the visible component and the ultraviolet lamp assembly and defines an external light blocking space having an openable inlet in a lower portion of the body.

Abstract: Provided is a glucose sensor. The glucose sensor according to the present invention includes noble metal-graphene composites, and has high sensitivity and significantly excellent current flow as compared to titanium dioxide-graphene composites. In addition, the noble metal-graphene composite manufactured by aerosol spray pyrolysis serves as an improved glucose sensor having desirable sensitivity, stability, reproducibility, and selectivity.